Pregnancy following oestrogen receptor-positive breast cancer is safe

European Breast Cancer Conference - success and future

Advocating for metastatic breast cancer patients

Mouse models of metastatic breast cancer

Advanced breast cancer consensus and the latest on triple negative breast cancer

Cancer survivorship: NCI research and insights

A pregnancy pill to prevent breast cancer?

Chemothereapy with endocrine therapy and bisphosphonates in early breast cancer

Anti-HER2 treatment in metastatic breast cancer: trastuzumab and beyond

Results of seven year intraoperative radiation therapy trial

Endocrine management of breast cancer and advanced breast cancer

Non-drug treatments to help alleviate symptoms of treatment-induced menopause

15-year follow-up on radiotherapy treatment after surgery for ductal carcinoma in situ

Need for updated breast cancer guidelines and screening programs

FLIMS workshop and management of triple negative breast cancer

Debate on breast cancer screening contributing to drop in mortality

Triple negative advanced breast cancer treatment with PARP inhibitors

Highlights from EBCC 8 and looking to EBCC 9

ECCO and cancer care in Europe

Managing the toxicity of aromatase inhibitors

New technology for identifying and removing micro metastases in breast cancer patients

Managing HER2 overexpression in breast cancer

Debate on the success of breast cancer screening programmes

Analysis of thirty years of clinical trial data

Cost of MRI screening for women with a family history of breast cancer

Effectiveness of breast cancer screening

Results from national breast cancer screening programme